LY2181308
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LY2181308, covering 2008-08-29 to 2019-05-24. Get the full timeline:
Most recent: Clinical Trial Update: Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer [Phase 2]